Review



pakt r d systems mab7419 wb mouse  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 88
      Buy from Supplier

    Structured Review

    R&D Systems pakt r d systems mab7419 wb mouse
    Pakt R D Systems Mab7419 Wb Mouse, supplied by R&D Systems, used in various techniques. Bioz Stars score: 88/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+pakt/Human+Phospho-Akt1+(T308)+Antibody/pmc12453065__iovs-66-12-45_s001-42-121-122
    Average 88 stars, based on 10 article reviews
    pakt r d systems mab7419 wb mouse - by Bioz Stars, 2026-11
    88/100 stars

    Images

    Related Articles

    other:

    Article Title: Hyaluronic acid restored protein permeability across injured human lung microvascular endothelial cells.
    Article Snippet: For the primary antibodies, rat anti- human/mouse CD44 (#14- 0441- 85, Thermo Fischer Scientific), rabbit anti- human ZO- 1 (#5406, Cell Signaling Technology), rabbit anti- human VE- cadherin (#2158, Cell Signaling Technology), rabbit anti- human HMGA2 (#5269, Cell Signaling Technology), mouse anti- human pAKT (#MAB887, R&D Systems), mouse anti- human AKT (# MAB2055, R&D Systems), mouse anti- human caspase- 3 (#31A1067, Novus Biologicals, LLC), and mouse antihuman GAPDH (#MAB5718, R&D Systems) were used.



    Similar Products

    pakt r d systems mab7419 wb mouse  (R&D Systems)
    88
    R&D Systems pakt r d systems mab7419 wb mouse
    Pakt R D Systems Mab7419 Wb Mouse, supplied by R&D Systems, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+pakt/Human+Phospho-Akt1+(T308)+Antibody/pmc12453065__iovs-66-12-45_s001-42-121-122
    Average 88 stars, based on 1 article reviews
    pakt r d systems mab7419 wb mouse - by Bioz Stars, 2026-11
    88/100 stars
    		  Buy from Supplier
    apc anti-human/mouse pakt (s473)  (Thermo Fisher)
    90
    Thermo Fisher apc anti-human/mouse pakt (s473)
    Apc Anti Human/Mouse Pakt (S473), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+pakt/phospho+akt+1+2+3++ser473++instantonetm+elisa+kit/10__3389_slash_fimmu__2025__1552394-363-16-22
    Average 90 stars, based on 1 article reviews
    apc anti-human/mouse pakt (s473) - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    mouse anti pakt antibodies  (R&D Systems)
    93
    R&D Systems mouse anti pakt antibodies
    The figure illustrates the inhibitory effects of AMD3100 and A1 on CXCL12-induced AKT phosphorylation in CT-26 treated cells. In panel ( A ), representative Western blot images depict the expression of phosphorylated AKT <t>(pAKT)</t> <t>and</t> <t>Actin-β</t> (as a loading control) in cells subjected to 100 ng/mL of CXCL12 alongside increasing concentrations of either AMD3100 or A1 (0, 5, and 10 µM). The treatment with AMD3100 and A1 resulted in a noticeable reduction in pAKT levels compared to the control group. Panels ( B ) and ( C ) quantify the relative pAKT expression normalized to Actin-β for AMD3100 and A1, respectively. In panel ( B ), cells treated with 10 µM AMD3100 exhibited a statistically significant decrease in pAKT levels compared to both the control (***p < 0.001) and the 5 µM groups (**p < 0.01). Conversely, the difference between the control and the 5 µM groups was not statistically significant. In panel (C), A1 treatment demonstrated a significant reduction in pAKT levels in both the 5 µM (****p < 0.0001) and 10 µM (***p < 0.001) groups in comparison to the control, with the 10 µM group exhibiting a further reduction relative to the 5 µM group (****p < 0.0001). Statistical analysis was performed utilizing one-way ANOVA followed by Tukey’s post hoc test, and the data are presented as mean ± SEM from three independent experiments
    Mouse Anti Pakt Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+pakt/Human%2FMouse+Phospho-Akt+(S473)+Pan+Specific+Antibody/pmc11702187-117-13-16
    Average 93 stars, based on 1 article reviews
    mouse anti pakt antibodies - by Bioz Stars, 2026-11
    93/100 stars
    		  Buy from Supplier
    mouse anti human pakt  (R&D Systems)
    93
    R&D Systems mouse anti human pakt
    The figure illustrates the inhibitory effects of AMD3100 and A1 on CXCL12-induced AKT phosphorylation in CT-26 treated cells. In panel ( A ), representative Western blot images depict the expression of phosphorylated AKT <t>(pAKT)</t> <t>and</t> <t>Actin-β</t> (as a loading control) in cells subjected to 100 ng/mL of CXCL12 alongside increasing concentrations of either AMD3100 or A1 (0, 5, and 10 µM). The treatment with AMD3100 and A1 resulted in a noticeable reduction in pAKT levels compared to the control group. Panels ( B ) and ( C ) quantify the relative pAKT expression normalized to Actin-β for AMD3100 and A1, respectively. In panel ( B ), cells treated with 10 µM AMD3100 exhibited a statistically significant decrease in pAKT levels compared to both the control (***p < 0.001) and the 5 µM groups (**p < 0.01). Conversely, the difference between the control and the 5 µM groups was not statistically significant. In panel (C), A1 treatment demonstrated a significant reduction in pAKT levels in both the 5 µM (****p < 0.0001) and 10 µM (***p < 0.001) groups in comparison to the control, with the 10 µM group exhibiting a further reduction relative to the 5 µM group (****p < 0.0001). Statistical analysis was performed utilizing one-way ANOVA followed by Tukey’s post hoc test, and the data are presented as mean ± SEM from three independent experiments
    Mouse Anti Human Pakt, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+pakt/Human%2FMouse+Phospho-Akt+(S473)+Pan+Specific+Antibody/pm36089980-62-40-45
    Average 93 stars, based on 1 article reviews
    mouse anti human pakt - by Bioz Stars, 2026-11
    93/100 stars
    		  Buy from Supplier
    anti human pakt  (R&D Systems)
    93
    R&D Systems anti human pakt
    The figure illustrates the inhibitory effects of AMD3100 and A1 on CXCL12-induced AKT phosphorylation in CT-26 treated cells. In panel ( A ), representative Western blot images depict the expression of phosphorylated AKT <t>(pAKT)</t> <t>and</t> <t>Actin-β</t> (as a loading control) in cells subjected to 100 ng/mL of CXCL12 alongside increasing concentrations of either AMD3100 or A1 (0, 5, and 10 µM). The treatment with AMD3100 and A1 resulted in a noticeable reduction in pAKT levels compared to the control group. Panels ( B ) and ( C ) quantify the relative pAKT expression normalized to Actin-β for AMD3100 and A1, respectively. In panel ( B ), cells treated with 10 µM AMD3100 exhibited a statistically significant decrease in pAKT levels compared to both the control (***p < 0.001) and the 5 µM groups (**p < 0.01). Conversely, the difference between the control and the 5 µM groups was not statistically significant. In panel (C), A1 treatment demonstrated a significant reduction in pAKT levels in both the 5 µM (****p < 0.0001) and 10 µM (***p < 0.001) groups in comparison to the control, with the 10 µM group exhibiting a further reduction relative to the 5 µM group (****p < 0.0001). Statistical analysis was performed utilizing one-way ANOVA followed by Tukey’s post hoc test, and the data are presented as mean ± SEM from three independent experiments
    Anti Human Pakt, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+pakt/Human%2FMouse+Phospho-Akt+(S473)+Pan+Specific+Antibody/pmc09447422-65-33-36
    Average 93 stars, based on 1 article reviews
    anti human pakt - by Bioz Stars, 2026-11
    93/100 stars
    		  Buy from Supplier
    anti pakt  (R&D Systems)
    93
    R&D Systems anti pakt
    The figure illustrates the inhibitory effects of AMD3100 and A1 on CXCL12-induced AKT phosphorylation in CT-26 treated cells. In panel ( A ), representative Western blot images depict the expression of phosphorylated AKT <t>(pAKT)</t> <t>and</t> <t>Actin-β</t> (as a loading control) in cells subjected to 100 ng/mL of CXCL12 alongside increasing concentrations of either AMD3100 or A1 (0, 5, and 10 µM). The treatment with AMD3100 and A1 resulted in a noticeable reduction in pAKT levels compared to the control group. Panels ( B ) and ( C ) quantify the relative pAKT expression normalized to Actin-β for AMD3100 and A1, respectively. In panel ( B ), cells treated with 10 µM AMD3100 exhibited a statistically significant decrease in pAKT levels compared to both the control (***p < 0.001) and the 5 µM groups (**p < 0.01). Conversely, the difference between the control and the 5 µM groups was not statistically significant. In panel (C), A1 treatment demonstrated a significant reduction in pAKT levels in both the 5 µM (****p < 0.0001) and 10 µM (***p < 0.001) groups in comparison to the control, with the 10 µM group exhibiting a further reduction relative to the 5 µM group (****p < 0.0001). Statistical analysis was performed utilizing one-way ANOVA followed by Tukey’s post hoc test, and the data are presented as mean ± SEM from three independent experiments
    Anti Pakt, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+pakt/Human%2FMouse+Phospho-Akt+(S473)+Pan+Specific+Antibody/pm35625614-133-46-50
    Average 93 stars, based on 1 article reviews
    anti pakt - by Bioz Stars, 2026-11
    93/100 stars
    		  Buy from Supplier
    anti human mouse pakt  (fluidigm)
    92
    fluidigm anti human mouse pakt
    The figure illustrates the inhibitory effects of AMD3100 and A1 on CXCL12-induced AKT phosphorylation in CT-26 treated cells. In panel ( A ), representative Western blot images depict the expression of phosphorylated AKT <t>(pAKT)</t> <t>and</t> <t>Actin-β</t> (as a loading control) in cells subjected to 100 ng/mL of CXCL12 alongside increasing concentrations of either AMD3100 or A1 (0, 5, and 10 µM). The treatment with AMD3100 and A1 resulted in a noticeable reduction in pAKT levels compared to the control group. Panels ( B ) and ( C ) quantify the relative pAKT expression normalized to Actin-β for AMD3100 and A1, respectively. In panel ( B ), cells treated with 10 µM AMD3100 exhibited a statistically significant decrease in pAKT levels compared to both the control (***p < 0.001) and the 5 µM groups (**p < 0.01). Conversely, the difference between the control and the 5 µM groups was not statistically significant. In panel (C), A1 treatment demonstrated a significant reduction in pAKT levels in both the 5 µM (****p < 0.0001) and 10 µM (***p < 0.001) groups in comparison to the control, with the 10 µM group exhibiting a further reduction relative to the 5 µM group (****p < 0.0001). Statistical analysis was performed utilizing one-way ANOVA followed by Tukey’s post hoc test, and the data are presented as mean ± SEM from three independent experiments
    Anti Human Mouse Pakt, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+pakt/Anti-pAkt+%5BS473%5D+(D9E)-152Sm/pm34297917-256-218-224
    Average 92 stars, based on 1 article reviews
    anti human mouse pakt - by Bioz Stars, 2026-11
    92/100 stars
    		  Buy from Supplier
    anti human mouse pakt t308 clone d25e6  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc anti human mouse pakt t308 clone d25e6

    Anti Human Mouse Pakt T308 Clone D25e6, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+pakt/Phospho-Akt+(Thr308)+XP+Rabbit+mAb/pmc08443274-128-0-6
    Average 96 stars, based on 1 article reviews
    anti human mouse pakt t308 clone d25e6 - by Bioz Stars, 2026-11
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    The figure illustrates the inhibitory effects of AMD3100 and A1 on CXCL12-induced AKT phosphorylation in CT-26 treated cells. In panel ( A ), representative Western blot images depict the expression of phosphorylated AKT (pAKT) and Actin-β (as a loading control) in cells subjected to 100 ng/mL of CXCL12 alongside increasing concentrations of either AMD3100 or A1 (0, 5, and 10 µM). The treatment with AMD3100 and A1 resulted in a noticeable reduction in pAKT levels compared to the control group. Panels ( B ) and ( C ) quantify the relative pAKT expression normalized to Actin-β for AMD3100 and A1, respectively. In panel ( B ), cells treated with 10 µM AMD3100 exhibited a statistically significant decrease in pAKT levels compared to both the control (***p < 0.001) and the 5 µM groups (**p < 0.01). Conversely, the difference between the control and the 5 µM groups was not statistically significant. In panel (C), A1 treatment demonstrated a significant reduction in pAKT levels in both the 5 µM (****p < 0.0001) and 10 µM (***p < 0.001) groups in comparison to the control, with the 10 µM group exhibiting a further reduction relative to the 5 µM group (****p < 0.0001). Statistical analysis was performed utilizing one-way ANOVA followed by Tukey’s post hoc test, and the data are presented as mean ± SEM from three independent experiments

    Journal: Cancer Cell International

    Article Title: A1, an innovative fluorinated CXCR4 inhibitor, redefines the therapeutic landscape in colorectal cancer

    doi: 10.1186/s12935-024-03584-y

    Figure Lengend Snippet: The figure illustrates the inhibitory effects of AMD3100 and A1 on CXCL12-induced AKT phosphorylation in CT-26 treated cells. In panel ( A ), representative Western blot images depict the expression of phosphorylated AKT (pAKT) and Actin-β (as a loading control) in cells subjected to 100 ng/mL of CXCL12 alongside increasing concentrations of either AMD3100 or A1 (0, 5, and 10 µM). The treatment with AMD3100 and A1 resulted in a noticeable reduction in pAKT levels compared to the control group. Panels ( B ) and ( C ) quantify the relative pAKT expression normalized to Actin-β for AMD3100 and A1, respectively. In panel ( B ), cells treated with 10 µM AMD3100 exhibited a statistically significant decrease in pAKT levels compared to both the control (***p < 0.001) and the 5 µM groups (**p < 0.01). Conversely, the difference between the control and the 5 µM groups was not statistically significant. In panel (C), A1 treatment demonstrated a significant reduction in pAKT levels in both the 5 µM (****p < 0.0001) and 10 µM (***p < 0.001) groups in comparison to the control, with the 10 µM group exhibiting a further reduction relative to the 5 µM group (****p < 0.0001). Statistical analysis was performed utilizing one-way ANOVA followed by Tukey’s post hoc test, and the data are presented as mean ± SEM from three independent experiments

    Article Snippet: Subsequently, proteins were separated by SDS-PAGE electrophoresis, transferred onto membranes, and immunoblotted with mouse anti-pAKT antibodies (R&D System, MAB887-SP) along with anti-actin β antibodies (R&D System, MAB8929-SP) for normalization.

    Techniques: Phospho-proteomics, Western Blot, Expressing, Control, Comparison

    Journal: Cancer Cell

    Article Title: Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity

    doi: 10.1016/j.ccell.2021.06.017

    Figure Lengend Snippet:

    Article Snippet: Anti-human/mouse pAKT [T308] clone D25E6 , Cell Signaling Technology , 13038.

    Techniques: Blocking Assay, Virus, Recombinant, Plasmid Preparation, Saline, Lysis, Staining, Reverse Transcription, In Vivo, Electroporation, Mass Cytometry, Conjugation Assay, Illumina Sequencing, Library Quantification, In Vitro, Quantitative RT-PCR, Software, Real-time Polymerase Chain Reaction, Cytometry, Microscopy, Imaging, Spectrophotometry